CTVA
Price
$12.26
Change
+$0.38 (+3.20%)
Updated
Nov 4 closing price
Capitalization
8.18B
6 days until earnings call
Intraday BUY SELL Signals
NTR
Price
$72.93
Change
+$0.86 (+1.19%)
Updated
Nov 5, 12:19 PM (EDT)
Capitalization
34.39B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTVA vs NTR

CTVA vs NTR Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Oct 20, 2026

Which Stock Would AI Choose? Corteva, Inc. (CTVA) vs. Nutrien Ltd. (NTR) Stock Comparison

Key Takeaways

  • Corteva (CTVA) is a pure-play agriculture technology company centered on seeds and crop protection, while Nutrien (NTR) is an integrated fertilizer producer and the world's largest potash supplier.
  • Corteva has emphasized margin expansion, seed licensing growth, and a planned separation of its businesses in the second half of 2026.
  • Nutrien has shown strong relative performance, supported by higher potash and nitrogen prices, portfolio simplification, and record upstream sales volumes.
  • The two companies face different risk profiles: Corteva is exposed to seed-licensing and crop-protection pricing, while Nutrien is tied to commodity fertilizer cycles.
  • Both stocks sit within the agriculture complex, making their relative performance a useful lens on distinct parts of the farm-economy value chain.

Introduction

Agriculture is a cyclical and capital-intensive sector, yet the companies operating within it are far from interchangeable. This stock comparison examines CTVA (Corteva, Inc.), a global seed and crop-protection leader, alongside NTR (Nutrien Ltd.), one of the largest integrated fertilizer producers in the world. Although both generate revenue from farmers, they occupy different positions in the input supply chain. Investors focused on agricultural technology, licensing economics, and structural margin improvement may gravitate toward Corteva, while those seeking exposure to commodity fertilizer pricing and scale in nutrient production may find Nutrien more relevant. Comparing their recent market positioning and fundamentals offers a clearer view of where value and momentum currently reside.

CTVA Overview and Recent Performance

Corteva, Inc. operates across two primary segments: Seed and Crop Protection. The company has positioned itself around differentiated seed technologies, biologicals, and an expanding out-licensing model for its genetic traits. In recent market activity, CTVA has benefited from improving sentiment tied to margin expansion and progress on a planned corporate separation expected to be completed in the second half of 2026. Management has highlighted full-year operating EBITDA (earnings before interest, taxes, depreciation, and amortization) growth and a push beyond a 22% operating margin for the first time as a public company.

A notable catalyst has been a comprehensive legal resolution with Bayer that provides multi-year clarity on technology access and licensing rights. This agreement is expected to accelerate Corteva's path to royalty neutrality and support its long-term goal of becoming a net out-licensor of seed technology. In the Crop Protection business, pricing pressure in Latin America and Asia Pacific has remained a headwind, although new products and biologicals have supported volume growth. Overall, recent performance reflects a company balancing structural productivity gains against a still-uneven commodity input environment.

NTR Overview and Recent Performance

Nutrien Ltd. is a vertically integrated agricultural inputs company with a large retail network and one of the world's leading wholesale fertilizer operations. It produces roughly 20% of global potash supply and is a major nitrogen and phosphate producer. In recent weeks, NTR has demonstrated strong relative performance, with shares advancing well ahead of its industry over the trailing year. This momentum has been underpinned by higher potash and nitrogen selling prices, record upstream fertilizer sales volumes, and improved reliability across its nitrogen operations.

Nutrien has also advanced a portfolio-simplification strategy, completing the sale of its 50% stake in Argentina's Profertil nitrogen venture for approximately $600 million and initiating a strategic review of its phosphate business, which contributes a relatively small share of EBITDA. Retail segment results have been supported by cost-reduction initiatives and growth in proprietary product margins. These actions reflect a focus on earnings quality, free cash flow, and shareholder returns, even as the company manages challenges such as the controlled shutdown of its Trinidad nitrogen operations.

Trending AI Robots

Tickeron maintains hundreds of AI Trading Bots that trade across thousands of different tickers, each with its own trading style, strategy, timeframe, performance history, and set of securities. Because not every bot suits every market environment, Tickeron curates only the most suitable performers into its Trending AI Robots section. These bots are selected to reflect current market conditions, with some positioned for short-term momentum and others designed for longer-horizon trend-following. For traders comparing stocks like CTVA and NTR, reviewing bot statistics such as win rates, trade frequency, and drawdown metrics can add a quantitative layer to fundamental analysis. Explore the Trending AI Robots page to see which strategies are currently leading.

Head-to-Head Comparison

The core contrast between these two names is business model. Corteva is a technology and licensing-oriented business whose growth increasingly depends on seed innovation, royalty economics, and biologicals, with a relatively lighter exposure to raw commodity pricing. Nutrien, by contrast, is a capital-intensive producer whose earnings are closely tied to global potash, nitrogen, and phosphate prices, amplified by its scale as the largest potash producer worldwide.

On recent momentum, Nutrien has shown notably stronger relative performance, aided by constructive fertilizer pricing and record volumes. Corteva's narrative is more structural, centered on margin expansion, the Bayer resolution, and the upcoming separation rather than a sharp cyclical upswing. Risk profiles differ accordingly: Nutrien carries commodity-price and supply-cycle risk, while Corteva faces competitive pricing in crop protection and execution risk around its planned split. Sentiment also diverges, with analysts generally constructive on both names but framing Corteva around long-term technology optionality and Nutrien around near-term earnings leverage to fertilizer markets.

Tickeron AI Verdict

Based on observable factors, Tickeron's AI would likely lean toward NTR in the current environment. Nutrien's stronger relative momentum, favorable fertilizer pricing trends, and record upstream volumes suggest more consistent and measurable near-term catalysts. Corteva's structural story remains compelling, particularly its licensing economics and planned separation, but its drivers are longer-dated and depend on execution milestones. Because AI-driven models tend to favor trend consistency and recent relative strength, Nutrien currently presents the more probabilistically favorable setup, though both names retain distinct merits depending on an investor's timeframe and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
CTVA vs. NTR commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTVA is a Buy and NTR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CTVA with price predictions
Nov 04, 2026

CTVA's RSI Oscillator recovers from oversold territory

The RSI Indicator for CTVA moved out of oversold territory on October 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In 23 of the 29 cases the stock moved higher. This puts the odds of a move higher at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 53 cases where CTVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

Following a +3.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTVA advanced for three days, in 217 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

CTVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTVA as a result. In 48 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for CTVA turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 25 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

CTVA moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CTVA crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

The Aroon Indicator for CTVA entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. CTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.325) is normal, around the industry mean (-0.427). P/E Ratio (8.013) is within average values for comparable stocks, (8.568). Projected Growth (PEG Ratio) (1.011) is also within normal values, averaging (0.867). Dividend Yield (0.025) settles around the average of (0.130) among similar stocks. CTVA's P/S Ratio (3.069) is slightly higher than the industry average of (1.476).

The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for NTR with price predictions
Nov 04, 2026

NTR's RSI Indicator ascends from oversold territory

The RSI Oscillator for NTR moved out of oversold territory on October 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 20 of the 24 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on NTR as a result. In 55 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for NTR just turned positive on October 23, 2026. Looking at past instances where NTR's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.

Following a +2.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTR advanced for three days, in 229 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for NTR crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

NTR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NTR entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. NTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.328) is normal, around the industry mean (-0.427). P/E Ratio (14.589) is within average values for comparable stocks, (8.568). NTR's Projected Growth (PEG Ratio) (1.982) is slightly higher than the industry average of (0.867). Dividend Yield (0.031) settles around the average of (0.130) among similar stocks. P/S Ratio (1.329) is also within normal values, averaging (1.476).

The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

FUNDAMENTALS RATINGS
CTVA vs NTR: Fundamental Ratings
CTVA
NTR
OUTLOOK RATING
1..100
9115
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
2284
SMR RATING
1..100
8573
PRICE GROWTH RATING
1..100
4746
P/E GROWTH RATING
1..100
9578
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTVA's Valuation (50) in the null industry is in the same range as NTR (70) in the Chemicals Agricultural industry. This means that CTVA’s stock grew similarly to NTR’s over the last 12 months.

CTVA's Profit vs Risk Rating (22) in the null industry is somewhat better than the same rating for NTR (84) in the Chemicals Agricultural industry. This means that CTVA’s stock grew somewhat faster than NTR’s over the last 12 months.

NTR's SMR Rating (73) in the Chemicals Agricultural industry is in the same range as CTVA (85) in the null industry. This means that NTR’s stock grew similarly to CTVA’s over the last 12 months.

NTR's Price Growth Rating (46) in the Chemicals Agricultural industry is in the same range as CTVA (47) in the null industry. This means that NTR’s stock grew similarly to CTVA’s over the last 12 months.

NTR's P/E Growth Rating (78) in the Chemicals Agricultural industry is in the same range as CTVA (95) in the null industry. This means that NTR’s stock grew similarly to CTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTVANTR
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
58%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
55%
Bearish Trend 8 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
68%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (CTVA: $12.26 vs. NTR: $72.07)
Brand notoriety: CTVA and NTR are both not notable
Both companies represent the Chemicals: Agricultural industry
Current volume relative to the 65-day Moving Average: CTVA: 67% vs. NTR: 131%
Market capitalization -- CTVA: $8.18B vs. NTR: $34.39B
CTVA [@Chemicals: Agricultural] is valued at $8.18B. NTR’s [@Chemicals: Agricultural] market capitalization is $34.39B. The market cap for tickers in the [@Chemicals: Agricultural] industry ranges from $611 to $34.39B. The average market capitalization across the [@Chemicals: Agricultural] industry is $5.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTVA’s FA Score shows that 1 FA rating(s) are green while NTR’s FA Score has 0 green FA rating(s).

  • CTVA’s FA Score: 1 green, 4 red.
  • NTR’s FA Score: 0 green, 5 red.
According to our system of comparison, CTVA is a better buy in the long-term than NTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTVA’s TA Score shows that 4 TA indicator(s) are bullish while NTR’s TA Score has 4 bullish TA indicator(s).

  • CTVA’s TA Score: 4 bullish, 6 bearish.
  • NTR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NTR is a better buy in the short-term than CTVA.

Price Growth

CTVA (@Chemicals: Agricultural) experienced а +8.21% price change this week, while NTR (@Chemicals: Agricultural) price change was +4.34% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Agricultural industry was +0.48%. For the same industry, the average monthly price growth was -14.52%, and the average quarterly price growth was -17.42%.

Reported Earning Dates

CTVA is expected to report earnings on Nov 11, 2026.

NTR is expected to report earnings on Feb 17, 2027.

Industries' Descriptions

@Chemicals: Agricultural (+0.48% weekly)

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

View a ticker or compare two or three
Interact to see
Advertisement

CTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTVA has been loosely correlated with NTR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CTVA jumps, then NTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTVA
1D Price
Change %
CTVA100%
+3.20%
NTR - CTVA
45%
Loosely correlated
+3.97%
FMC - CTVA
36%
Loosely correlated
+5.42%
MOS - CTVA
32%
Poorly correlated
+17.37%
CF - CTVA
29%
Poorly correlated
-4.39%
IPI - CTVA
28%
Poorly correlated
+1.72%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRU82.133.58
+4.56%
TransUnion
SRG1.760.07
+4.14%
Seritage Growth Properties
EJH1.290.05
+4.03%
E-Home Household Service Holdings Limited
IMMX7.970.26
+3.37%
Immix Biopharma
GLXY13.97-2.86
-16.99%
Galaxy Digital Inc